Importantly inhibition of PI3K-C2β has been shown to inhibit early stage of neuroblastoma formation34 and ovarian cancer metastasis formation33 in animal models, supporting the conclusion that this enzyme may represent a novel interesting target in anti-cancer therapy. This evidence concerns the gene SCGB2B3P and ovarian cancer.